A phase 1 trial of VTx-002 for the treatment of ALS
Latest Information Update: 18 Jun 2024
At a glance
- Drugs Tamuzimod (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Biomarker
Most Recent Events
- 18 Jun 2024 New trial record
- 17 Jun 2024 According to a UMC media release, first patient enrolled.
- 17 Jun 2024 According to a UMC media release, study results will be published in a peer-reviewed journal, contributing to the scientific community's understanding of ALS and its treatment.